Preserving the intellectual output & resources of the University of Missouri.
Bisphosphonate therapy: When not to monitor BMD
MOspace/Manakin Repository
Breadcrumbs Navigation
Bisphosphonate therapy: When not to monitor BMD
Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/5447
| Title: | Bisphosphonate therapy: When not to monitor BMD |
| Author: | Sharma, Umang; Stevermer, James J.; Hickner, John |
| Keywords: |
osteoporosis
fragility fractures DXA scan |
| Date: | 2009-11 |
| Publisher: | Family Physicians Inquiries Network |
| Citation: | Journal of Family Practice, 58(11) 2009: 594-596. |
| Abstract: | After starting patients on bisphosphonates for osteoporosis, wait at least 3 years before ordering a repeat dual-energy x-ray absorptiometry (DXA) scan. Strength of Recommendation: C: Based on a secondary analysis of a large randomized controlled trial. |
| URI: | http://hdl.handle.net/10355/5447 |
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
-
Priority Updates to Research Literature (PURLs) [107]
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.